NHS Framework for the Midlands and East, Branded Medicines - Tranche B

NHS EnglandcontractContracts FinderRef CF-0124600D0O000000rwimUAA1SME suitablecomplete

Estimated value

£228.2m

Awarded value

£228.2m

Awarded 25 Jan 2021

Suppliers

1

Lots

1

1 awarded

Published

23 Apr 2021

Deadline 05 Nov 2020

Other contracts from NHS England· 10

Most recent notices published by the same contracting authority.

View buyer profile →

Other contracts awarded to Accord-UK Ltd,AMGEN LIMITED,Astrazeneca Plc,AVENTIS PHARMA LIMITED,Bayer Ltd,Biogen,Bristol Myers Squibb,Celltrion Healthcare United Kingdom Limited,CST Pharma Limited,Daiichi Sankyo UK Ltd,Day Lewis Medical Ltd,Dr.Reddy's Laboratories (UK) Limited,Eli Lilly & Company Ltd,Ferring Pharmaceuticals Ltd,Gedeon Richter UK Ltd,Gilead Sciences Limited,Ipsen,Janssen-Cilag Ltd,LEO Pharma,Merck Serono Limited,Merck Sharpe & Dohme (UK) Limited,Mylan,Napp Pharmaceuticals Ltd,Novartis Pharmaceuticals UK Ltd,Novo Nordisk,Organon Pharmaceuticals,Pfizer Ltd,Roche Products Ltd,ROVI Biotech Ltd,Sandoz Ltd,Sobi (Swedish Orphan Biovitrum Ltd),Takeda UK Ltd,Techdow Pharma England Ltd,Teva UK Limited,Thornton and Ross Ltd,UCB Pharma Ltd,UL Global Pharma· 0

Cross-buyer view of this supplier's public-sector wins.

View supplier profile →

No related contracts found.